A method and application of increasing lincomycin production by modifying the gene of Streptomyces lincomycin SLCG_2390
By modifying the SLCG_2390 gene in Streptococcus lincosids and constructing a high-yield strain, the problem of low lincomycin yield in the existing technology was solved, and the lincomycin yield was improved, and technical support for industrial production was provided.
Patent Information
- Application Number
- CN202410699989.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-31
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-05-31
AI Technical Summary
The existing technology is difficult to effectively increase the yield of lincomycin, resulting in the industrial fermentation yield of lincomycin strains in my country being lower than that of foreign countries, and lacks efficient genetic engineering methods for strain-oriented transformation.
Highly yielded strains were constructed to increase the yield of lincomycin by screening and modifying highly homologous SLCG_2390 genes in Streptocytica and deletion or overexpression through genetic engineering pathways.
By knocking out the SLCG_2390 gene, the yield of lincomycin A is increased by 20%, while the yield recovers or decreases after recovery or overexpression, indicating that the SLCG_2390 gene negatively regulates lincomycin synthesis, providing a technique to increase lincomycin production support.
Smart Images

Figure CN118421674B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of genetic engineering, and in particular to a method and application of increasing the yield of lincomycin by transforming the gene of Streptomyces lincomycin SLCG_2390. Background Art
[0002] The morphological differentiation and secondary metabolism of Streptomyces occur synchronously, and regulatory genes play an important role in this process. Regulatory factors can not only affect the morphological differentiation of Streptomyces, but also regulate the secondary metabolism of Streptomyces. Moreover, these metabolic regulatory pathways are not isolated, but tend to form a complex network, and there are superposition and cascade effects between each network. The current research on regulatory factors related to these important metabolic processes has enabled us to establish a metabolic regulatory network in Streptomyces. Changes in a single regulatory network node will have an impact on the metabolic hierarchy of Streptomyces, and the search and research of key metabolic regulatory network nodes will provide deep theoretical support for further analysis of the complex life history of Streptomyces and their transformation and utilization.
[0003] Streptomyces lincomycin is a major actinomycete in the industrial fermentation production of lincomycin. Among them, the active A component is used to treat infections caused by Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae and some anaerobic Gram-negative bacteria. It does not show cross-resistance with known antibiotics and is an important and highly effective antibiotic drug. Lincomycin has strong penetration into tissues and cells and is easy to use without skin tests. Therefore, it can replace penicillin, which is prone to allergic reactions, to a certain extent and is widely used in clinical practice. In addition, lincomycin can also be used as a raw material drug to chemically semi-synthesize the more important clinical drug clindamycin, which has a high economic added value. my country is the main producer and exporter of lincomycin raw materials and occupies an important position in the global fermentation production of lincomycin. However, the industrial fermentation of lincomycin strains in my country is 8-10g / L, which is still behind the advanced level of foreign countries (about 15g / L). As one of the important ways to obtain high-yield antibiotic strains, genetic engineering methods urgently need to explore the biosynthesis of lincomycin and its regulatory pathways, so as to carry out targeted transformation of lincomycin industrial strains.
[0004] The TPR family regulatory factor NsdA in Streptomyces can regulate the synthesis and morphological differentiation of antibiotics. The present invention screened the SLCG_2390 gene that is highly homologous to the nsdA gene in Streptomyces lincomycin through bioinformatics comparison analysis (the homology with the nsdA gene of Streptomyces coelicolor is as high as 88%). Based on this, an attempt was made to increase the yield of lincomycin by modifying the SLCG_2390 gene of Streptomyces lincomycin. Summary of the invention
[0005] The technical problem to be solved by the present invention is to provide a method and application for increasing the yield of lincomycin by transforming the gene of Streptomyces lincomycin SLCG_2390.
[0006] The present invention adopts the following technical solutions to solve the above technical problems:
[0007] A method for increasing the yield of lincomycin by modifying the SLCG_2390 gene of Streptomyces lincomycin, wherein the SLCG_2390 gene in Streptomyces lincomycin is deleted through genetic engineering to obtain a high-yield lincomycin strain, and the obtained strain is used to ferment and produce lincomycin; wherein the nucleotide sequence of the SLCG_2390 gene is shown in SEQ ID NO.1.
[0008] As one of the preferred embodiments of the present invention, the amino acid sequence encoded by the SLCG_2390 gene is shown in SEQ ID NO.2.
[0009] As one of the preferred embodiments of the present invention, the SLCG_2390 gene expression product negatively regulates lincomycin biosynthesis.
[0010] An application of the method for increasing the yield of lincomycin by modifying the SLCG_2390 gene of Streptomyces lincomycin is to knock out the SLCG_2390 gene in an industrial strain of Streptomyces lincomycin to obtain a high-yield mutant for lincomycin A production.
[0011] As one of the preferred embodiments of the present invention, the industrial strain of Streptomyces lincomyces is specifically selected from Streptomyces lincomyces LC-G. The Streptomyces lincomyces LC-G is a strain that can be directly purchased by the public and is deposited in the China General Microbiological Culture Collection Center with a deposit number of CGMCC: 7.209.
[0012] The advantages of the present invention compared to the prior art are:
[0013] In the present invention, the negative regulator of lincomycin biosynthesis SLCG_2390 was screened out, and the SLCG_2390 gene on the genome of Streptomyces lincomycin was knocked out by genetic engineering, so that a high-yield strain of lincomycin can be constructed, providing technical support for increasing the yield of lincomycin in industrial production.
[0014] Specifically, by knocking out the SLCG_2390 gene in lincomycin LC-G, the lincomycin A production can be increased by 20%; by complementing the SLCG_2390 gene in the ΔSLCG_2390 mutant, the lincomycin production was restored; by overexpressing the SLCG_2390 gene in LC-G, the lincomycin A production was reduced by 35%; the above indicates that the expression product of the SLCG_2390 gene, SLCG_2390, negatively regulates the synthesis of lincomycin A. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 It is a location information diagram of the SLCG_2390 gene and its surrounding adjacent genes on the genome in Example 1;
[0016] Figure 2 is a schematic diagram of the construction of the ΔSLCG_2390 mutant in Example 2;
[0017] Figure 3 This is a diagram of the PCR identification results of ΔSLCG_2390 in Example 2 (in the figure, "M": 5000 bp DNA Marker; "+": pKC1139-Δ2390; "-": LC-G; "2, 3": ΔSLCG_2390);
[0018] Figure 4 is a graph showing the measurement results of the dry weight of lincomycin mycelium of Streptomyces lincomycin LC-G and the ΔSLCG_2390 mutant in Example 3;
[0019] Figure 5 It is the construction and PCR identification diagram of the pKC1139-2390 plasmid map in Example 4 (in the figure, Figure A is the construction diagram of the pKC1139-2390 plasmid map, and Figure B is the PCR identification diagram of pKC1139-2390; and in Figure B, "M": 5000bp DNA Marker; "+": LC-G; "-": pKC1139; "1": pKC1139-2390);
[0020] Figure 6 It is the PCR identification diagram of the complemented strain ΔSLCG_2390 / pKC1139-2390 and the overexpression strain; LC-G / pKC1139-2390 in Example 4 (in the figure, "M": 5000bp DNA Marker; "+": pKC1139; "-": LC-G; "1-3": ΔSLCG_2390 / pKC1139-2390; "4-6": LC-G / pKC1139-2390);
[0021] Figure 7 1 is a graph showing the HPLC analysis results of lincomycin A production in the SLCG_2390 gene series strains in Example 5 (in the graph, "**" indicates P<0.01);
[0022] Figure 8 is a graph showing the spore morphology observation results of strains LC-G and ΔSLCG_2390 in Example 6;
[0023] Fig. 9This is a graph showing the transcription analysis results of lmbU, lmbR, lmbA, amfC, whiB and ftsZ in LC-G and ΔSLCG_2390 in Example 7 (in the graph, "***" indicates P < 0.001; "*" indicates P < 0.05). DETAILED DESCRIPTION
[0024] The following is a detailed description of an embodiment of the present invention. This embodiment is implemented on the premise of the technical solution of the present invention, and a detailed implementation method and a specific operation process are given, but the protection scope of the present invention is not limited to the following embodiment.
[0025] The strains and plasmids used in the following examples are shown in Table 1, and the synthesized primer sequences are shown in Table 2. The Escherichia coli used in the examples were cultured in liquid LB medium at 37°C or on solid LB plates supplemented with 1.25% agar. Streptomyces lincomycin was cultured in tryptone soy broth (TSBY) medium at 30°C or on modified Gould's 1 (MGM) plates containing 1.8% agar.
[0026] PEG3350, lysozyme, TES, thiostrepton, and apramycin used in the following examples were purchased from Sigma. TSB, yeast extract, and peptone were purchased from Oxoid. Glycine, agar powder, sodium chloride, and other biological reagents were purchased from a reagent company. General operation techniques for Escherichia coli and Streptomyces lincomycin were performed according to standard procedures. Primer synthesis and DNA sequencing were performed by Sangon Biotech (Shanghai) Co., Ltd.
[0027] Table 1 The present invention relates to strains and plasmids
[0028]
[0029]
[0030] Table 2 The present invention relates to primers
[0031]
[0032]
[0033] Example 1
[0034] SLCG_2390 gene related information:
[0035] Based on the gene annotation information of KEGG database (https: / / www.kegg.jp / ), the location information of SLCG_2390 and its surrounding genes in the genome of S. lincomyces and their potential gene functions are as follows Figure 1 shown.
[0036] The nucleotide sequence of the SLCG_2390 gene is shown in SEQ ID NO.1, with a total length of 1494 bp; the encoded amino acid sequence is shown in SEQ ID NO.2.
[0037] Example 2
[0038] Construction of SLCG_2390 knockout strain (ΔSLCG_2390):
[0039] SLCG_2390 gene knockout process Figure 2 shown.
[0040] Using the primer pairs 2390-UF / R and 2390-DF / R in Table 2, the genomic DNA of Streptomyces lincosus LC-G was used as a template to amplify the homology arms of about 1.5 kb upstream and downstream of the SLCG_2390 gene. Then, the two homology arms were connected to pKC1139 to construct the recombinant plasmid pKC1139-Δ2390. The pKC1139-Δ2390 plasmid was transformed into the ET12567 (pUZ8002) host, and the plasmid was introduced into LC-G by mycelial conjugation transfer. The conjugate was cultured at 37°C, and clones resistant to apramycin were screened, i.e., single exchange mutants. The single exchange strain was screened by numerical non-selective pressure to obtain a strain sensitive to apramycin. The mutant strain with SLCG_2390 gene deletion was further verified by PCR and named ΔSLCG_2390. The identification primers used were 2390-VF / R (Table 2). The schematic diagram of double exchange is shown in Figure 2 , genomic PCR results are shown in Figure 3 , a 1.5 kb band was obtained by PCR amplification of the LC-G genome of the starting strain, and a 0.6 kb band was obtained by PCR amplification of the genome of the ΔSLCG_2390 deletion strain.
[0041] Example 3
[0042] Mycelial biomass detection of Streptomyces lincomyces LC-G and ΔSLCG_2390 mutant strains:
[0043] LC-G and ΔSLCG_2390 were inoculated into 5 mL of liquid TSBY with the same inoculation amount. After culturing at 30°C for 48 h, equal amounts of LC-G and ΔSLCG_2390 bacterial suspension were taken into YMG medium and cultured at 30°C and 240 rpm for 7 days. During this period, 1 mL of bacterial suspension was taken out every 24 hours and centrifuged at 12000 rpm for 10 min, and the supernatant was discarded; 1 mL of anhydrous ethanol was added to wash the bacteria, centrifuged at 12000 rpm for 10 min, and the supernatant was discarded; the wet bacteria were placed in a 65°C oven for 2 days and weighed, and the bacterial mass was recorded. The dry weight of LCGL and ΔSLCG_2390 bacteria was plotted according to the growth time to draw the bacterial biomass curve ( Figure 4 shown).
[0044] Example 4
[0045] Construction of SLCG_2390 gene complementation strain (ΔSLCG_2390 / pKC1139-2390) and overexpression strain (LC-G / pKC1139-2390):
[0046] In order to further confirm the regulatory effect of SLCG_2390 gene on lincomycin production, LC-G genomic DNA was used as a template and primers 2390-CO-F / R (Table 2) were used to amplify the complete SLCG_2390 gene by PCR and cloned into the pBlueScript II SK(+) plasmid. The correctly sequenced fragment was cloned into the pJTU968 plasmid via NdeI / EcoRI. The SLCG_2390 fragment with ermE* promoter was obtained by MunI / EcoRI digestion and cloned into the EcoRI site of pKC1139 to obtain the SLCG_2390 gene complementation plasmid pKC1139-2390 ( Figure 5 A). Using primer 2390-CO-F / R, PCR amplification of bacterial solution obtained a 1.5 kb band ( Figure 5 B), pKC1139-2390 was introduced into the ΔSLCG_2390 mutant and the starting strain LC-G by protoplast transformation, and transformants resistant to apramycin were selected. The aac(3)IV-F / R primers were used for verification, and a 0.75 kb band was obtained by PCR amplification ( Figure 6 As shown), the SLCG_2390 gene complemented strain ΔSLCG_2390 / pKC1139-2390 and the complemented control strain ΔSLCG_2390 / pKC1139 were successfully constructed, as well as the overexpression strain LC-G / pKC1139-2390 and the overexpression control strain LC-G / pKC1139.
[0047] Example 5
[0048] HPLC detection of fermentation products of SLCG_2390 gene series strains:
[0049] The LC-G, ΔSLCG_2390, ΔSLCG_2390 / pKC1139, ΔSLCG_2390 / pKC1139-2390, LC-G / pKC1139, and LC-G / pKC1139-2390 strains were fermented, and their fermentation products were detected by HPLC.
[0050] The results are as follows Figure 7As shown: Taking lincomycin A as the characterization, compared with the starting strain LC-G, the lincomycin A production of ΔSLCG_2390 increased by 20%; compared with the starting strain LC-G, the lincomycin production of the complemented strain recovered to 90%; compared with the starting strain LC-G, the lincomycin production of the overexpression strain decreased by 25%. The above shows that SLCG_2390 can negatively regulate the production of lincomycin.
[0051] Example 6
[0052] Observation of spore morphology of ΔSLCG_2390 and LC-G:
[0053] To analyze whether the deletion of SLCG_2390 gene affects spore morphology, morphological differentiation experiments were performed on LC-G, ΔSLCG_2390, ΔSLCG_2390 / pKC1139, and ΔSLCG_2390 / pKC1139-2390 using MGM medium as spore production medium. Photos were taken every 24 hours for morphological observation, and the spore morphologies of 2d, 3d, and 4d were selected for comparison.
[0054] The results are as follows Figure 8 As shown: Compared with the starting strain LC-G, the spore production of ΔSLCG_2390 was delayed, while the spore morphology of the complemented strain ΔSLCG_2390 / pKC1139-2390 did not completely return to the level of the starting strain.
[0055] Example 7
[0056] Transcriptional level analysis of related genes in ΔSLCG_2390 and LC-G:
[0057] Referring to the fermentation culture method of the strain in Example 5, the bacterial precipitates of ΔSLCG_2390 and LC-G fermented for 24 hours were collected by centrifugation, and the total RNA of the above bacteria was extracted using the TransZol kit, and cDNA was obtained by DNA digestion and RNA inversion, and qRT-PCR detection and analysis were performed using the relevant primers in Table 2.
[0058] The results are as follows Fig. 9 As shown in the figure: Compared with LC-G, the transcription levels of the regulatory gene lmbU and the synthetic gene lmbR in the ΔSLCG_2390 mutant were upregulated, and the transcription level of lmbA did not change significantly, which was consistent with the fermentation results. In addition, considering that the SLCG_2390 gene deletion had a certain effect on the spore morphology in the morphological differentiation experiment, the transcription levels of the genes amfC, whiB, and ftsZ related to spore morphology were subsequently detected; compared with LC-G, the transcription levels of the whiB and ftsZ genes in the ΔSLCG_2390 strain were reduced, while the transcription level of the amfC gene did not change significantly.
[0059] The above results indicate that SLCG_2390 can inhibit the transcription of lmbU and lmbR, and activate the transcription of whiB and ftsZ.
[0060] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for modifying Streptomyces lincomyces SLCG_2390 A method for genetically increasing lincomycin production, characterized in that: Through genetic engineering, Streptomyces lincomyces SLCG_2390 The gene is deleted to obtain a high-yield strain of lincomycin, and the obtained strain is used to ferment and produce lincomycin; wherein the lincomycin Streptomyces is lincomycin Streptomyces LC-G, which is deposited in the China General Microbiological Culture Collection Center with a deposit number of CGMCC: 7.209; SLCG_2390 The nucleotide sequence of the gene is shown in SEQ ID NO.1; the lincomycin produced by fermentation is lincomycin A.
2. The method according to claim 1, wherein the modified Streptomyces lincomyces SLCG_2390 A method for genetically increasing lincomycin production, characterized in that: Said SLCG_2390 The amino acid sequence encoded by the gene is shown in SEQ ID NO.
2.
3. The method according to claim 1 for modifying Streptomyces lincomyces SLCG_2390 A method for genetically increasing lincomycin production, characterized in that: Said SLCG_2390 The gene expression product negatively regulates lincomycin biosynthesis.
4. A modified Streptomyces lincomyces as claimed in any one of claims 1 to 3 SLCG_2390 The application of the method for increasing lincomycin production by gene is characterized in that: Knockout in industrial strains of Streptomyces lincomyces SLCG_2390 Gene, to obtain a high-yield mutant strain for lincomycin production; the lincomycin is lincomycin A.
